Oral mixture of autologous colon-extracted proteins for the Crohn’s disease: A double-blind trial

Figure 1 Effect of oral administration of Alequel^TM on clinical remission. Percent of subjects in clinical remission (Crohn’s disease activity index < 150) during the course of the study. Black bars represent the Alequel^TM-treated group and open bars represent the placebo group. The evaluable number of patients in each group was too small to reach a statistical significance.